17- N,N- diethylcarbamoyl- 4- methyl- 4- azaandrostane- 3- one

inhibitor of testosterone 5-alpha reductase, receptor binding & nuclear uptake of androgens in the prostate

Also Known As:

DMAA; 17 beta- N,N- diethylcarbamoyl- 4- methyl- 4- aza- 5 alpha-androstan-3-one; 17- N,N- diethyl- 4- methyl- 3- oxo- 4- azaandrostane- 17- carboxamide; 4MA compound; 4-Azaandrostane-17-carboxamide, N,N-diethyl-4-methyl-3-oxo-, (5alpha,17beta)-

Pharmalogical Action Categories:

D000726 - Androgen Antagonists
D058891 - 5-alpha Reductase Inhibitors

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Androstanes: 11
      - Androstanols
        Dihydrotestosterone: 1732
        17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one: 155
    - Heterocyclic Steroids: 4
      - Azasteroids: 4
        17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one: 155
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gonadal Hormones: 716
    - Gonadal Steroid Hormones: 7657
      - Testosterone Congeners: 112
        Dihydrotestosterone: 1732
        17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one: 155

Eduardo Rodríguez-Vellando Rubio Selected Research

Eduardo Rodríguez-Vellando Rubio Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure